We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+1.77%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$301M
Cap. Flow
+$293M
Cap. Flow %
57.02%
Top 10 Hldgs %
5.45%
Holding
1,025
New
585
Increased
167
Reduced
66
Closed
207

Top Buys

Rank Stock Value
1
SSRM icon
SSR Mining
SSRM
+$4.08M
2
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$3.92M
3
SMAR
Smartsheet Inc.
SMAR
+$2.98M
4
LEN icon
Lennar Class A
LEN
+$2.74M
5
DOW icon
Dow Inc
DOW
+$2.55M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$2.12M
2
HOLX
Hologic
HOLX
+$2.01M
3
MPC icon
Marathon Petroleum
MPC
+$1.66M
4
KO icon
Coca-Cola
KO
+$1.58M
5
JBL icon
Jabil
JBL
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 22.07%
2 Industrials 18.09%
3 Consumer Discretionary 13.93%
4 Healthcare 10.29%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APA icon
826
APA Corp
APA
$13.2B
– –
-31,023
Closed -$1.11M
APLD icon
827
Applied Digital
APLD
$8.41B
– –
-10,533
Closed -$71K
APP icon
828
Applovin
APP
$116B
– –
-8,748
Closed -$349K
APPF icon
829
AppFolio
APPF
$7.04B
– –
-1,220
Closed -$211K
ARDX icon
830
Ardelyx
ARDX
$997M
– –
-17,360
Closed -$108K
ARIS
831
DELISTED
Aris Water Solutions
ARIS
– –
-28,602
Closed -$240K
ARLO icon
832
Arlo Technologies
ARLO
$1.65B
– –
-19,652
Closed -$187K
ARMK icon
833
Aramark
ARMK
$14.7B
– –
-33,962
Closed -$954K
ARW icon
834
Arrow Electronics
ARW
$10.4B
– –
-3,790
Closed -$463K
ASUR icon
835
Asure Software
ASUR
$250M
– –
-12,872
Closed -$123K
AXGN icon
836
Axogen
AXGN
$2.5B
– –
-20,799
Closed -$142K
AXP icon
837
American Express
AXP
$230B
– –
-1,202
Closed -$225K
BDX icon
838
Becton Dickinson
BDX
$48.2B
– –
-3,466
Closed -$845K
BGFV
839
DELISTED
Big 5 Sporting Goods
BGFV
– –
-18,588
Closed -$118K
BIO icon
840
Bio-Rad Laboratories Class A
BIO
$9.42B
– –
-1,238
Closed -$400K
BKR icon
841
Baker Hughes
BKR
$61.1B
– –
-29,931
Closed -$1.02M
BLNK icon
842
Blink Charging
BLNK
$87.9M
– –
-28,912
Closed -$98K
BLUE
843
DELISTED
bluebird bio
BLUE
– –
-2,330
Closed -$64.3K
BPOP icon
844
Popular Inc
BPOP
$11.1B
– –
-5,593
Closed -$459K
BSX icon
845
Boston Scientific
BSX
$71.5B
– –
-21,545
Closed -$1.25M
CAG icon
846
Conagra Brands
CAG
$7.23B
– –
-20,222
Closed -$580K
CASY icon
847
Casey's General Stores
CASY
$30.9B
– –
-1,148
Closed -$315K
CCCC icon
848
C4 Therapeutics
CCCC
$412M
– –
-11,131
Closed -$62.9K
CDE icon
849
Coeur Mining
CDE
$17.9B
– –
-49,233
Closed -$161K
CDLX icon
850
Cardlytics
CDLX
$21.5M
– –
-1,826
Closed -$168K
32 33
34
35 36

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Sherbrooke Park Advisers held 1,025 positions worth $514M, up 141% from $213M the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.

Sherbrooke Park Advisers deployed $293M of net new capital in Q1 2024, opening 585 new positions and adding to 167 existing holdings. Its largest new stake was Amylyx Pharmaceuticals: 299,452 shares worth $850K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Procter & Gamble, an estimated $2.12M trimmed.

  • Sherbrooke Park Advisers's largest Q1 2024 buy was Amylyx Pharmaceuticals: 299,452 shares worth $850K.
  • Sherbrooke Park Advisers added most to SSR Mining in Q1 2024, an estimated $4.08M increase.
  • Sherbrooke Park Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $2.12M.
  • Sherbrooke Park Advisers fully exited Hologic in Q1 2024, selling an estimated $2.01M.
  • Sherbrooke Park Advisers's ten largest holdings make up 5.5% of its $514M portfolio in Q1 2024.
  • Sherbrooke Park Advisers opened 585 new positions and closed 207 in Q1 2024.
  • Sherbrooke Park Advisers's portfolio value rose 141% quarter-over-quarter to $514M.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2024, filed 15 May 2024.